JP

Jatin M. Patel

BS Bristol-Myers Squibb: 7 patents #758 of 3,969Top 20%
AA Astrazeneca Ab: 3 patents #459 of 1,971Top 25%
AL Astrazeneca Uk Limited: 2 patents #48 of 159Top 35%
TQ The University Of Queensland: 2 patents #101 of 555Top 20%
Pfizer: 1 patents #3,022 of 5,153Top 60%
📍 Plainsboro, NJ: #212 of 1,381 inventorsTop 20%
🗺 New Jersey: #7,307 of 69,400 inventorsTop 15%
Overall (All Time): #412,125 of 4,157,543Top 10%
12
Patents All Time

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDate
11045502 Method of isolating cells for therapy and prophylaxis Paul Kiarash Khosrotehrani, Nicholas Maxwell Fisk 2021-06-29
10149864 Method of isolating cells for therapy and prophylaxis Paul Kiarash Khosrotehrani, Nicholas Maxwell Fisk 2018-12-11
9616028 Bilayer tablet formulations Admassu Abebe, Kyle Martin, Divyakant Desai, Peter Timmins 2017-04-11
9326945 Apixaban formulations Charles Frost, Jingpin Jia, Chandra Vemavarapu 2016-05-03
9198925 Pharmaceutical formulations containing an SGLT2 inhibitor Dilbir S. Bindra, Mandar V. Dali, Prakash V. Parab, Li Tao, Ravindra W. Tejwani +2 more 2015-12-01
9050258 Bilayer tablet formulations Admassu Abebe, Kyle Martin, Divyakant Desai, Peter Timmins 2015-06-09
8716251 Pharmaceutical formulations containing an SGLT2 inhibitor Dilbir S. Bindra, Mandar V. Dali, Prakash V. Parab, Li Tao, Ravindra W. Tejwani +2 more 2014-05-06
8535715 Bilayer tablet formulations Admassu Abebe, Kyle Martin, Divyakant Desai, Peter Timmins 2013-09-17
8361972 Pharmaceutical formulations containing an SGLT2 inhibitor Dilbir S. Bindra, Mandar V. Dali, Prakash V. Parab, Li Tao, Ravindra W. Tejwani +2 more 2013-01-29
8221786 Pharmaceutical formulations containing an SGLT2 inhibitor Dilbir S. Bindra, Mandar V. Dali, Prakash V. Parab, Li Tao, Ravindra W. Tejwani +2 more 2012-07-17
7851502 Pharmaceutical formulations containing an SGLT2 inhibitor Dilbir S. Bindra, Mandar V. Dali, Prakash V. Parab, Li Tao, Ravindra W. Tejwani +2 more 2010-12-14
6034085 Salt form of nefazodone for use in extended release formulations Hemant Joshi, Terry D. Wilson 2000-03-07